Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Neurology. 2000 Aug 8;55(3):448-50.

Retrospective analysis of the use of cyclosporine in myasthenia gravis.

Author information

  • 1Department of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC 27710, USA.

Abstract

The authors reviewed the records of patients with myasthenia gravis who took cyclosporine for at least 6 months between November 1987 and January 1999. Of 57 patients who took cyclosporine for an average of 3.5 years, 55 (96%) had clinical improvement. The median time to best clinical response was 7 months. Corticosteroids were discontinued or decreased in 95% of 38 patients taking them. Major side effects included elevated serum creatinine (28%) and malignancy (11%). Five percent could not afford or tolerate the drug.

PMID:
10932288
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire
    Loading ...
    Write to the Help Desk